Cargando…
The Tumor Vessel Targeting Strategy: A Double-Edged Sword in Tumor Metastasis
Tumor vessels provide essential paths for tumor cells to escape from the primary tumor and form metastatic foci in distant organs. The vessel targeting strategy has been widely used as an important clinical cancer chemotherapeutic strategy for patients with metastatic tumors. Our review introduces t...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6952935/ https://www.ncbi.nlm.nih.gov/pubmed/31835465 http://dx.doi.org/10.3390/cells8121602 |
_version_ | 1783486534838648832 |
---|---|
author | Li, Xiaobo Li, Yong Lu, Weijin Chen, Minfeng Ye, Wencai Zhang, Dongmei |
author_facet | Li, Xiaobo Li, Yong Lu, Weijin Chen, Minfeng Ye, Wencai Zhang, Dongmei |
author_sort | Li, Xiaobo |
collection | PubMed |
description | Tumor vessels provide essential paths for tumor cells to escape from the primary tumor and form metastatic foci in distant organs. The vessel targeting strategy has been widely used as an important clinical cancer chemotherapeutic strategy for patients with metastatic tumors. Our review introduces the contribution of angiogenesis to tumor metastasis and summarizes the application of Food and Drug Administration (FDA)-approved vessel targeting drugs for metastatic tumors. We recommend the application and mechanisms of vascular targeting drugs for inhibiting tumor metastasis and discuss the risk and corresponding countermeasures after vessel targeting treatment. |
format | Online Article Text |
id | pubmed-6952935 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-69529352020-01-23 The Tumor Vessel Targeting Strategy: A Double-Edged Sword in Tumor Metastasis Li, Xiaobo Li, Yong Lu, Weijin Chen, Minfeng Ye, Wencai Zhang, Dongmei Cells Review Tumor vessels provide essential paths for tumor cells to escape from the primary tumor and form metastatic foci in distant organs. The vessel targeting strategy has been widely used as an important clinical cancer chemotherapeutic strategy for patients with metastatic tumors. Our review introduces the contribution of angiogenesis to tumor metastasis and summarizes the application of Food and Drug Administration (FDA)-approved vessel targeting drugs for metastatic tumors. We recommend the application and mechanisms of vascular targeting drugs for inhibiting tumor metastasis and discuss the risk and corresponding countermeasures after vessel targeting treatment. MDPI 2019-12-10 /pmc/articles/PMC6952935/ /pubmed/31835465 http://dx.doi.org/10.3390/cells8121602 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Li, Xiaobo Li, Yong Lu, Weijin Chen, Minfeng Ye, Wencai Zhang, Dongmei The Tumor Vessel Targeting Strategy: A Double-Edged Sword in Tumor Metastasis |
title | The Tumor Vessel Targeting Strategy: A Double-Edged Sword in Tumor Metastasis |
title_full | The Tumor Vessel Targeting Strategy: A Double-Edged Sword in Tumor Metastasis |
title_fullStr | The Tumor Vessel Targeting Strategy: A Double-Edged Sword in Tumor Metastasis |
title_full_unstemmed | The Tumor Vessel Targeting Strategy: A Double-Edged Sword in Tumor Metastasis |
title_short | The Tumor Vessel Targeting Strategy: A Double-Edged Sword in Tumor Metastasis |
title_sort | tumor vessel targeting strategy: a double-edged sword in tumor metastasis |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6952935/ https://www.ncbi.nlm.nih.gov/pubmed/31835465 http://dx.doi.org/10.3390/cells8121602 |
work_keys_str_mv | AT lixiaobo thetumorvesseltargetingstrategyadoubleedgedswordintumormetastasis AT liyong thetumorvesseltargetingstrategyadoubleedgedswordintumormetastasis AT luweijin thetumorvesseltargetingstrategyadoubleedgedswordintumormetastasis AT chenminfeng thetumorvesseltargetingstrategyadoubleedgedswordintumormetastasis AT yewencai thetumorvesseltargetingstrategyadoubleedgedswordintumormetastasis AT zhangdongmei thetumorvesseltargetingstrategyadoubleedgedswordintumormetastasis AT lixiaobo tumorvesseltargetingstrategyadoubleedgedswordintumormetastasis AT liyong tumorvesseltargetingstrategyadoubleedgedswordintumormetastasis AT luweijin tumorvesseltargetingstrategyadoubleedgedswordintumormetastasis AT chenminfeng tumorvesseltargetingstrategyadoubleedgedswordintumormetastasis AT yewencai tumorvesseltargetingstrategyadoubleedgedswordintumormetastasis AT zhangdongmei tumorvesseltargetingstrategyadoubleedgedswordintumormetastasis |